Emmessar Biotech & Nutrition Ltd.
Snapshot View

25.90 +0.30 ▲1.2%

27 January 2023, 04:01:00 PM
Volume: 53

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ebnl.org
Market Cap 12.94 Cr.
Enterprise Value(EV) 8.45 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.07 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 24.28 Trailing Twelve Months Ending 2022-09
Industry PE 33.61 Trailing Twelve Months Ending 2022-09
Book Value / Share 13.01 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.99 Calculated using Price: 25.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.50 Cr. 4,996,100 Shares
FaceValue 10
Company Profile
Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.17%
1 Week
+1.77%
1 Month
-5.82%
3 Month
+12.36%
6 Month
+14.35%
1 Year
-18.17%
2 Year
+50.14%
5 Year
-20.55%
10 Year
+271.06%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -17.71 -7.98 -40.75 78.73 36.00 16.42 19.40 29.10 8.01
Return on Capital Employed (%) -9.52 -10.49 -59.37 79.46 31.46 9.00 18.87 45.29 15.71
Return on Assets (%) -8.60 -5.08 -20.32 44.83 26.93 12.75 14.93 22.47 6.30

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 2 1 1 2 3 4 4 6 6 7
Non Curr. Liab. 0 0 1 1 0 0 0 0 0
Curr. Liab. 0 1 1 0 0 1 1 2 1 0
Minority Int.
Equity & Liab. 2 2 2 3 4 5 5 7 8 7
Non Curr. Assets 2 2 1 2 2 2 2 2 2 2
Curr. Assets 1 1 1 1 1 3 3 6 6 5
Misc. Exp. not W/O
Total Assets 2 2 2 3 4 5 5 7 8 7

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 1 2 2 3 1 1 3 7 0 1
Other Income 0 0 0 1 1 1 1 1 2 2
Total Income 1 2 2 4 3 2 5 8 2 3
Total Expenditure -1 -2 -2 -2 -2 -1 -4 -6 -1 -1
PBIDT 0 0 0 1 1 1 1 2 1 1
Interest 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 -1 0 -1
Exceptional Items -1 0 0
PAT 0 0 0 1 1 1 1 1 0 1
Adjusted EPS -1 0 -1 2 2 1 2 3 1 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 1 1 0 1 0 2
Cash Fr. Inv. 0 0 -1 -1 0 -1 0 -3
Cash Fr. Finan.
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 1 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 58.45 58.50 58.51 58.50 58.50 58.51 58.19 56.31 58.53
Public 41.55 41.50 41.49 41.50 41.50 41.49 41.81 43.69 41.47
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 20 Jan 2023
COMPLIANCE CERTIFICATE FOR THE QUARTER ENDED DECEMBER 31 2022.
Pursuant to Regulation 3(5) and 3(6) of the Securities & Exchange Board of India (Prohibition of Insider Trading) Regulation. We attaching the SDD Compliance Certificate for the quarter ended December 31 2022.
Tue, 10 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Kindly find attached the confirmation certificate received from our Registrar & Transfer Agent M/s. Link Intime India Pvt Ltd; vide their Letter dated January 09 2023 regarding Compliance Certificate Under Regulation 74(5) of SEBI (Depository & Participants) Regulations 2018 in relation to dematerialisation mutilation and cancellation of share certificates received for dematerialisation during the third quarter ended December 31 2022.You are kindly requested to take this on record and disseminate it for the information of investors
Tue, 10 Jan 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 47(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are attaching the newspaper clippings regarding the intimation of Board Meeting to be held on Saturday February 04 2023 at 03:30 pm. This is published in The Free Press Journal in English and Navshakti in Marathi dated January 10 2023.

Technical Scans View Details >>

Wed, 25 Jan 2023
High Delivery Percentage High Delivery Percentage
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
Closing Near 100 SMA Closing Near 100 SMA
William %R Bullish William %R Bullish

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,518.84 1,040.75 +0.1%
Divi's Laboratories Ltd. 88,552.35 3,385.55 +1.5%
Cipla Ltd. 83,862.25 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 69,879.98 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 60,777.77 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,497.96 1,537.85 -1.3%
Abbott India Ltd. 45,101.64 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.79 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.71 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 32.68 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 22.47 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.39 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 65.87 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.15 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.33 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 3.83 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.36 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.15 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.62 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.62 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Emmessar Biotech & Nutrition Ltd.

What is Emmessar Biotech&Nut share price?

Can I buy Emmessar Biotech&Nut shares now?

What is the Market Cap of Emmessar Biotech&Nut?

What are the key metrics to analyse Emmessar Biotech&Nut?

What is the 52 Week High and Low of Emmessar Biotech&Nut?

What is the trend of Emmessar Biotech&Nut share price?